{"transactions":[{"id":2885338,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":143195,"kind":"person","name":"Ginski Mark J","position":1,"cik":"0001843460","reported_name":"Ginski Mark J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VP, HEAD OF CMC"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-02T22:17:54.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares vest on the first anniversary of the grant date, and the remainder vests in 36 equal monthly installments thereafter over a period of three (3) years, becoming fully vested on February 1, 2025."}],"balance_after":200000,"derivative":{"exercise_price":2.14,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-21-000508","document":"form4-02022021_020242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588921000508/form4-02022021_020242.xml","form_type":"4"}}]}